Vermont Plaintiff Files Xarelto Lawsuit Alleging Drug Caused Father’s Fatal Uncontrollable Bleed

February 09, 2016 – – BloodThinnerHelp.com reports on the details of another lawsuit filed against the manufacturers of anticoagulant Xarelto: Bayer AG and Janssen Pharmaceuticals, (a division of the Johnson & Johnson corporation). The lawsuit was filed under case number 2:14-cv-00159-CR by a daughter on behalf of her deceased father in a Vermont federal courtroom. The complaint alleges that the plaintiff’s father’s uncontrollable bleeding episode and subsequent death was caused by Xarelto.

Further lawsuit details found within court documents show that the father was prescribed blood-thinning drug Xarelto in order to treat his atrial fibrillation condition. This is a heart condition that can sometimes put patients at increased risk for blood clots or strokes. Many patients who are diagnosed with the condition choose to use blood thinners as a preventative measure for these occurrences.

Although the father had taken Xarelto only a short time, when he suddenly injured himself and suffered a brain bleed, doctors could not get the blood to clot. He was diagnosed with a parenchymal hemorrhage, which is a type of intracerebral hemorrhage, and doctors worked to keep him alive for 6 days until he ultimately passed away from the bleed.

At the time of the plaintiff’s father’s bleed, Xarelto had no available antidote. The drug was sold to consumers without an antidote for four years, in fact. When patients who had taken Xarelto were injured and bleeding, doctors had nothing to treat them with to allow their blood to clot and prevent them from bleeding out. In these situations, the treating physicians would resort to extreme, life-saving measures such as surgeries or blood transfusions.

Traditional blood thinners, such as warfarin, were released with an available antidote through vitamin K. If someone who had used these types of blood thinners began to bleed, physicians were able to treat them with vitamin K, which would counteract the anticoagulant’s effects and allow their blood to form clots.

The plaintiff’s lawsuit claims that, at the time of her father’s death, manufacturers Janssen and Bayer showed reckless negligence by initially releasing a drug for consumer sales which had no corresponding antidote, and which could pose so many significant and potentially fatal bleeding dangers. In making these claims, the young woman is not alone. At this time, more than 2,800 federally-filed Xarelto lawsuits have been filed and consolidated by the U.S. Judicial Panel on Multidistrict Litigation under MDL number 2592. In addition to these, more than 550 other Xarelto lawsuits have been consolidated to form a mass tort litigation group in Philadelphia, Pennsylvania.

Attorney Joseph Osborne is currently working to help make sure that anyone who has been negatively affected by adverse health events associated with Xarelto will have the opportunity to fully explore their legal rights. These people may be entitled to substantial compensation. Attorney Osborne is offering complimentary legal consultations to affected individuals at this time.

To request more information on Xarelto lawsuits, or ask questions, contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008032